Jul 3, 2018   SOURCE: PR NewsWire

Atrial Fibrillation Devices 2018: Global Market Outlook to 2026 - Asia-Pacific is Expected to Exhibit Lucrative CAGR

DUBLIN, July 3, 2018 /PRNewswire/ --

The "Global Atrial Fibrillation Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The atrial fibrillation devices market was valued at US$ 4,884.9 Mn in 2017, and expected to reach US$ 17,867.3 Mn by 2026 at a CAGR of 15.6% during the forecast period from 2018 to 2026.

The global atrial fibrillation devices market exhibits remunerative growth during the forecast period from 2018 to 2026 due to technological advances in atrial fibrillation devices and significant rise in prevalence of hypertension & atrial fibrillation across the world.

Technological advances in atrial fibrillation devices including fluoroscopy integrated 3D mapping technology in ablation, which decreases radiation exposure and provide real-time 3D electromagnetic navigation. Innovative techniques such as convergent procedure, focal impulse and rotor modulation (FIRM) ablation, and WATCHMAN left atrial appendage closure (LAAC) procedure are gaining popularity among patients around the world.

Additionally, radiofrequency (RF) catheter ablation, microwave-based catheter ablation, cryoablation, and laser-based catheter ablation procedures are developed and expected to exhibit profitable market growth in near future.

As per the data published by the AtriCure, Inc., worldwide more than 33 million people are suffering from Atrial fibrillation (Afib). U.S. has 6 million Afib patients who incurred a total cost of US$ 26 billion for the disease in 2017. U.S. holds more than US$ 1.5 billion market for atrial fibrillation devices. An article published in the Journal of the American Society of Hypertension stated the worldwide prevalence of hypertension was 1.39 billion in 2010, which is anticipated to reach to 1.56 billion by 2025.

Key Market Movements

    --  Globally, the atrial fibrillation devices market continues to witness a
        lucrative growth at a CAGR of 15.6% for the period from 2018 to 2026
    --  Based on the product type, the electrophysiology (EP) ablation catheters
        segment spearheaded the market in 2017 due to increasing adoption of
        advanced procedures such as radiofrequency catheter ablation,
        microwave-based catheter ablation, cryoablation, and laser-based
        catheter ablation. This procedure is majorly used when patients are
        tolerant to anti-coagulation drugs.
    --  The cardiac monitors segment is expected to witness fastest market
        growth owing to the emergence of implantable cardiac monitors (ICMs) and
        worldwide adoption of other cardiac monitors such as holter monitor,
        event recorder, mobile cardiac telemetry (MCT) to monitor heart rhythms
    --  Global surge in the number of hospitals and comparatively higher
        adoption of atrial fibrillation devices during AF procedures in
        hospitals are putting the hospitals segment at the dominant position
    --  Higher presence of Afib patient population and rising adoption of
        advanced technologies in the U.S. and Canada, North America is likely to
        contribute maximum to the overall growth of atrial fibrillation devices
        market
    --  Asia Pacific is expected to exhibit lucrative CAGR over the forecast
        period due to growing awareness about Afib procedures, surging geriatric
        population, and increasing healthcare expenditure in India, China, and
        Japan
    --  Major players in this vertical are Medtronic; Boston Scientific
        Corporation; AtriCure, Inc.; Abbott Laboratories; Hansen Medical;
        Stereotaxis, Inc.; Biosense Webster, Inc.; Siemens Healthineers;
        BIOTRONIK SE & Co. KG; and CardioFocus, Inc.

Key Topics Covered

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Market Segmentation
1.3 Research Scope
1.4 Research Methodology
1.4.1 Phase I - Secondary Research
1.4.2 Phase II - Primary Research
1.4.3 Phase III - Expert Panel Review
1.4.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Atrial Fibrillation Devices Market Portraiture
2.2 Global Atrial Fibrillation Devices Market, by Product Type, 2017 (US$ Mn)
2.3 Global Atrial Fibrillation Devices Market, by End-use, 2017 (US$ Mn)
2.4 Global Atrial Fibrillation Devices Market, by Geography, 2017 (US$ Mn)

Chapter 3 Global Atrial Fibrillation Devices Market: Dynamics & Future Outlook
3.1 Market Overview
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Worldwide rising prevalence of obesity and hypertension
3.2.1.2 Technological advances in atrial fibrillation devices
3.2.1.3 Driver 3
3.2.1.4 Driver 4
3.2.2 Challenges
3.2.2.1 Challenge 1
3.2.2.2 Challenge 2
3.2.3 Opportunities
3.2.3.1 Opportunity 1
3.2.3.2 Opportunity 2
3.3 Attractive Investment Proposition, by Geography, 2017
3.4 Competitive Landscape, by Key Players, 2017

Chapter 4 Global Atrial Fibrillation Devices Market, by Product Type, 2016-2026 (US$ Mn)
4.1 Overview
4.2 Electrophysiology Ablation Catheters
4.3 Electrophysiology Diagnostic Catheters
4.3.1 Fixed Diagnostic Catheters
4.3.2 Steerable Diagnostic Catheters
4.3.3 Others (balloon catheters, microcatheters)
4.4 Electrophysiology Mapping and Recording Systems
4.5 Cardiac Monitors
4.6 Access Devices
4.7 Left Atrial Appendage (LAA) & Closure Devices
4.8 Intracardiac Echocardiography (ICE) Systems & Others

Chapter 5 Global Atrial Fibrillation Devices Market, by End-use, 2016-2026 (US$ Mn)
5.1 Overview
5.2 Hospitals
5.3 Clinics
5.4 Ambulatory Surgery Centers (ASCs)
5.5 Others (electrophysiology labs, catheterization laboratories)

Chapter 6 Global Atrial Fibrillation Devices Market, by Geography, 2016-2026 (US$ Mn)
6.1 Overview
6.2 North America Atrial Fibrillation Devices Market, 2016-2026 (US$ Mn)
6.2.1 North America Atrial Fibrillation Devices Market, by Product Type, 2016-2026 (US$ Mn)
6.2.2 North America Atrial Fibrillation Devices Market, by End-use, 2016-2026 (US$ Mn)
6.2.3 North America Atrial Fibrillation Devices Market, by Country, 2016-2026 (US$ Mn)
6.2.3.1 U.S.
6.2.3.2 Canada
6.3 Europe Atrial Fibrillation Devices Market, 2016-2026 (US$ Mn)
6.3.1 Europe Atrial Fibrillation Devices Market, by Product Type, 2016-2026 (US$ Mn)
6.3.2 Europe Atrial Fibrillation Devices Market, by End-use, 2016-2026 (US$ Mn)
6.3.3 Europe Atrial Fibrillation Devices Market, by Country/Region, 2016-2026 (US$ Mn)
6.3.3.1 U.K.
6.3.3.2 Germany
6.3.3.3 Rest of Europe
6.4 Asia Pacific Atrial Fibrillation Devices Market, 2016-2026 (US$ Mn)
6.4.1 Asia Pacific Atrial Fibrillation Devices Market, by Product Type, 2016-2026 (US$ Mn)
6.4.2 Asia Pacific Atrial Fibrillation Devices Market, by End-use, 2016-2026 (US$ Mn)
6.4.3 Asia Pacific Atrial Fibrillation Devices Market, by Country/Region, 2016-2026 (US$ Mn)
6.4.3.1 Japan
6.4.3.2 China
6.4.3.3 Rest of Asia Pacific
6.5 Latin America Atrial Fibrillation Devices Market, 2016-2026 (US$ Mn)
6.5.1 Latin America Atrial Fibrillation Devices Market, by Product Type, 2016-2026 (US$ Mn)
6.5.2 Latin America Atrial Fibrillation Devices Market, by End-use, 2016-2026 (US$ Mn)
6.5.3 Latin America Atrial Fibrillation Devices Market, by Country/Region, 2016-2026 (US$ Mn)
6.5.3.1 Brazil
6.5.3.2 Mexico
6.5.3.3 Rest of Latin America
6.6 Middle East & Africa Atrial Fibrillation Devices Market, 2016-2026 (US$ Mn)
6.6.1 Middle East & Africa Atrial Fibrillation Devices Market, by Product Type, 2016-2026 (US$ Mn)
6.6.2 Middle East & Africa Atrial Fibrillation Devices Market, by End-use, 2016-2026 (US$ Mn)
6.6.3 Middle East & Africa Atrial Fibrillation Devices Market, by Region, 2016-2026 (US$ Mn)
6.6.3.1 GCC
6.6.3.2 Rest of Middle East & Africa

Chapter 7 Company Profiles
7.1 AtriCure, Inc.
7.2 Boston Scientific Corporation
7.3 AtriCure, Inc.
7.4 Abbott Laboratories
7.5 Hansen Medical
7.6 Stereotaxis, Inc.
7.7 Biosense Webster, Inc.
7.8 Siemens Healthineers
7.9 BIOTRONIK SE & Co. KG
7.10 CardioFocus, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/cwflbq/atrial?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/atrial-fibrillation-devices-2018-global-market-outlook-to-2026---asia-pacific-is-expected-to-exhibit-lucrative-cagr-300675885.html

SOURCE Research and Markets